The Cell Therapy stream explores the critical challenges facing the analysis, quality and manufacture of cell-based therapies. Topics include product and process characterization, CMC strategies, autologous and allogeneic manufacturing strategies, automation and supply for CAR Ts and next-generation cell therapies such as NK cells, TIL and TCR-based therapies. The stream is paired with the Gene Therapy CMC and Analytics track.

Conferences Include:

Speaker Proposal